These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 15088287

  • 21. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M, Chladek J, Simkova M, Vaneckova J, Grim J, Martinkova J.
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Intermittent rises in plasma homocysteine in patients with rheumatoid arthritis treated with higher dose methotrexate.
    Hoekstra M, Haagsma CJ, Doelman CJ, van de Laar MA.
    Ann Rheum Dis; 2005 Jan; 64(1):141-3. PubMed ID: 15608313
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The effects of nonsteroidal antiinflammatory drugs on methotrexate (MTX) pharmacokinetics: impairment of renal clearance of MTX at weekly maintenance doses but not at 7.5 mg.
    Kremer JM, Hamilton RA.
    J Rheumatol; 1995 Nov; 22(11):2072-7. PubMed ID: 8596147
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Methotrexate pharmacokinetics in patients with rheumatoid arthritis.
    Sinnett MJ, Groff GD, Raddatz DA, Franck WA, Bertino JS.
    J Rheumatol; 1989 Jun; 16(6):745-8. PubMed ID: 2674426
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Low dose methotrexate therapy in chronic polyarthritis--an update].
    Leeb BF, Smolen JS.
    Acta Med Austriaca; 1996 Jun; 23(4):114-9. PubMed ID: 9036721
    [Abstract] [Full Text] [Related]

  • 34. Combined oral cyclosporin and methotrexate therapy in patients with rheumatoid arthritis elevates methotrexate levels and reduces 7-hydroxymethotrexate levels when compared with methotrexate alone.
    Fox RI, Morgan SL, Smith HT, Robbins BA, Choc MG, Baggott JE.
    Rheumatology (Oxford); 2003 Aug; 42(8):989-94. PubMed ID: 12730515
    [Abstract] [Full Text] [Related]

  • 35. Is there an optimal time to administer methotrexate in the treatment of rheumatoid arthritis?
    Carpentier N, Bertin P, Marquet P, Sabot C, Bonnet C, Debord J, Lachâtre G, Trèves R.
    J Rheumatol; 1998 Jul; 25(7):1270-5. PubMed ID: 9676755
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Pharmacokinetics and renal function in patients with rheumatoid arthritis receiving a standard dose of oral weekly methotrexate: association with significant decreases in creatinine clearance and renal clearance of the drug after 6 months of therapy.
    Kremer JM, Petrillo GF, Hamilton RA.
    J Rheumatol; 1995 Jan; 22(1):38-40. PubMed ID: 7699678
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.